Yingying Chen1, Ying He1, Jinwen Zhao1, Jin Zhang2, Ruo Yuan1, Shihong Chen1. 1. Key Laboratory of Luminescence Analysis and Molecular Sensing (Southwest University), Ministry of Education, College of Chemistry and Chemical Engineering, Southwest University, Chongqing 400715, P. R. China. 2. Chongqing Vocational Institute of Engineering, Chongqing 402260, P. R. China.
Abstract
The enrichment of co-reactants is one of the keys to improving the sensitivity of electrochemiluminescence (ECL) detection. This work developed a novel hydrophobic localized enrichment strategy of co-reactants utilizing the inner hydrophobic cavity of β-cyclodextrin (β-CD). Pt nanoparticles (Pt NPs) were grown in situ on the coordination sites for metal ions of β-CD to prepare the β-CD-Pt nanocomposite, which could not only enrich co-reactant 3-(dibutylamino) propylamine (TDBA) highly efficiently through its hydrophobic cavity but also immobilize TDBA via the Pt-N bond. Meanwhile, the carboxyl-functionalized poly[2,5-dioctyl-1,4-phenylene] (PDP) polymer nanoparticles (PNPs) were developed as excellent ECL luminophores. With SARS-CoV-2 nucleocapsid protein (ncovNP) as a model protein, the TDBA-β-CD-Pt nanocomposite combined PDP PNPs to construct a biosensor for ncovNP determination. The PDP PNPs were modified onto the surface of a glassy carbon electrode (GCE) to capture the first antibody (Ab1) and further capture antigen and secondary antibody complexes (TDBA-β-CD-Pt@Ab2). The resultant biosensor with a sandwich structure achieved a highly sensitive detection of ncovNP with a detection limit of 22 fg/mL. TDBA-β-CD-Pt shared with an inspiration in hydrophobic localized enrichment of co-reactants for improving the sensitivity of ECL detection. The luminophore PDP PNPs integrated TDBA-β-CD-Pt to provide a promising and sensitive ECL platform, offering a new method for ncovNP detection.
The enrichment of co-reactants is one of the keys to improving the sensitivity of electrochemiluminescence (ECL) detection. This work developed a novel hydrophobic localized enrichment strategy of co-reactants utilizing the inner hydrophobic cavity of β-cyclodextrin (β-CD). Pt nanoparticles (Pt NPs) were grown in situ on the coordination sites for metal ions of β-CD to prepare the β-CD-Pt nanocomposite, which could not only enrich co-reactant 3-(dibutylamino) propylamine (TDBA) highly efficiently through its hydrophobic cavity but also immobilize TDBA via the Pt-N bond. Meanwhile, the carboxyl-functionalized poly[2,5-dioctyl-1,4-phenylene] (PDP) polymer nanoparticles (PNPs) were developed as excellent ECL luminophores. With SARS-CoV-2 nucleocapsid protein (ncovNP) as a model protein, the TDBA-β-CD-Pt nanocomposite combined PDP PNPs to construct a biosensor for ncovNP determination. The PDP PNPs were modified onto the surface of a glassy carbon electrode (GCE) to capture the first antibody (Ab1) and further capture antigen and secondary antibody complexes (TDBA-β-CD-Pt@Ab2). The resultant biosensor with a sandwich structure achieved a highly sensitive detection of ncovNP with a detection limit of 22 fg/mL. TDBA-β-CD-Pt shared with an inspiration in hydrophobic localized enrichment of co-reactants for improving the sensitivity of ECL detection. The luminophore PDP PNPs integrated TDBA-β-CD-Pt to provide a promising and sensitive ECL platform, offering a new method for ncovNP detection.
Severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has
caused many deaths worldwide.[1] As one of
the four major structural proteins of SARS-CoV-2, the nucleocapsid
protein (NP) with the most abundant structural features was generally
considered as a biomarker of SARS-CoV-2.[2] Recently, several methods have been developed to detect the SARS-CoV-2
nucleocapsid protein (ncovNP), such as enzyme-linked immunosorbent
assays (ELISAs),[3] luciferase IP system
(LIPS),[4] and lateral flow assay (LFA).[5] However, those reported methods were characterized
by a low sensitivity or complex operation, so their applications were
limited.[6] The development of a sensitive
and simple test for ncovNP is critical.Electrochemiluminescence
(ECL) technology is characterized by low
background, high sensitivity, and simple operation and has attracted
extensive attention in clinical analysis, environmental monitoring,
and food safety.[7,8] The nucleic acid detection related
to SARS-CoV-2 using the ECL method has been reported.[9] The sensitivity of nucleic acid detection is relatively
high, but it has disadvantages such as cumbersome extraction process
and false-negative results.[10] Compared
with nucleic acid detection, protein detection is characterized by
a simpler operation, higher specificity, and higher accuracy.[11] So far, there are few reports concerning the
ECL protein detection of ncovNP. Thus, ECL strategies for ncovNP protein
detection are worth exploring.An excellent ECL luminophore
is one of the keys to achieving highly
sensitive ECL detection. Among the numerous ECL luminophores such
as organic polymers, inorganic complex, organic small molecules, and
inorganic nanomaterials such as metal nanoclusters and various quantum
dots, the organic polymers have received great attention due to their
high photostability, low cellular toxicity, and easy functionalization.[12,13] The organic polymers reported as ECL signal probes mainly include
polyfluorene and polyfluorene derivatives, poly(phenylenevinylene),
and heterocycle-containing polymers. For example, the polyfluorene
derivatives PFBT[13] and PFO[14] were developed as ECL luminophores to achieve true-color
ECL imaging for detecting multiplex and ratio detection of microRNA-155,
respectively. Cui’s group used heterocycle-containing thiophene-fused
conjugated microporous polymer with a strong dual-band bipolar ECL
emission to detect rhodamine B.[15] Ju’s
group prepared polymer dots containing poly(phenylenevinylene) CN-PPV
with high ECL efficiency to construct an ECL biosensor for detecting
Fe3+.[16] The types of organic
polymer reported in the literature are limited. It is significant
to develop new ECL polymer luminophores.The introduction of
co-reactants is also crucial for highly sensitive
ECL detection. The most common method to introduce co-reactants is
to add them directly into the detection solution. Such a method is
simple, but the stability and repeatability problems of the ECL system
cannot be ignored.[17] The in situ production
of co-reactants by the enzyme-catalyzed reaction faces complex operation
and harsh conditions of enzyme use, so its applications are limited.[18] Attaching co-reactants to the electrode surface
can overcome the disadvantage of introducing the co-reactants described
above, and some strategies such as covalent bonding and cross-linking
have been adopted.[19,20] However, it is still challenging
to achieve high loading of co-reactants on the electrode surface.
Since the hydrophobic localized enrichment can significantly enhance
the concentration of co-reactants on the electrode surface, enriching
co-reactants by the material with a hydrophobic cavity may be an ideal
choice to realize high loading of co-reactants on the electrode surface.
For example, Yuan’s group synthesized hydrophobic porous covalent
organic frameworks (COFs) as microreactors to provide co-reactants
with the microenvironment, thus achieving a confinement-enhanced ECL.[21] Yuan’s group also reported that the co-reactants
could be enriched around the electrode surface by hydrophobic interaction
between cholesterol and co-reactants.[22] However, the hydrophobic localized enrichment of co-reactants described
above was for the co-reactants present in the detection solution,
which still caused stability and repeatability problems in the ECL
system.[17] Therefore, it is of great value
to develop a material with an inner hydrophobic cavity for enriching
co-reactants to achieve their immobilization on the electrode surface.β-Cyclodextrin (β-CD) has an inner hydrophobic cavity
and an outer large number of the hydroxyl groups and has been widely
used for functionalization of materials, guest recognition, and coordination
with metal ions in the ECL field. For example, Chen’s group
applied β-CD-functionalized carbon nanohorns to detect naringin
based on the fact that naringin could enter into the cavity of β-CD
to form an inclusion complex.[23] He’s
group utilized the host–guest recognition between aptamer and
tris(bipyridine)ruthenium(II)-β-cyclodextrin for detecting thrombin.[24] Wei’s group utilized metal-binding sites
of β-CD to bind Pb2+ for synthesizing metal–organic
frameworks (MOFs).[25] In addition, the hydrophobic
nanocavity of β-CD could act as a nanoreactor, creating a restricted
system to accelerate electronic excitation.[26] The restriction effect of nanocavity and binding sites with metal
ions of β-CD may provide two completely different forces for
simultaneously immobilizing co-reactants, namely, hydrophobic localized
enrichment and covalent bonding through metal nanoparticles grown
in situ on β-CD.Inspired by the above observations, this
work developed a simple
and effective strategy for hydrophobic localized enrichment of co-reactant
3-(dibutylamino) propylamine (TDBA) utilizing the inner hydrophobic
cavity of β-CD. On the other hand, the coordination sites for
metal ions of β-CD make it easy for Pt nanoparticles (Pt NPs)
to grow in situ on β-CD, which could immobilize TDBA and the
second antibody (Ab2) via the Pt–N bond. Meanwhile,
the carboxyl-functionalized poly[2,5-dioctyl-1,4-phenylene] polymer
nanoparticles (PDP PNPs) were developed as luminophores. As seen from
its molecular structure in Scheme , obviously, PDP is different from other reported ECL
organic polymers, including polyfluorene derivatives, poly(phenylenevinylene),
and heterocycle-containing polymers, and is a kind of biphenyl polymer
with a relatively simple structure. PDP PNPs have good dispersibility
and stability in water, as well as excellent luminescence stability.
PDP PNPs were modified onto the GCE surface to capture the first antibody
(Ab1) and further capture ncovNP and the secondary antibody
complex (TDBA-β-CD-Pt@Ab2). Due to the systematic
action of hydrophobic localized enrichment and covalent bonding, the
amount of TDBA immobilized on the electrode surface was increased
significantly, and the ECL intensity was improved nearly fivefold
as compared to that without β-CD, thus achieving a sensitive
detection of ncovNP with a detection limit of 22 fg/mL. β-CD
provided an attractive strategy for high loading co-reactants on the
electrode surface. The integration of β-CD-Pt nanocomposites
as excellent carriers of co-reactants and PDP PNPs as an excellent
ECL luminophore would build an attractive ECL platform and shed light
on the ultrasensitive detection of ncovNP.
Scheme 1
Preparation of (A)
PDP PNPs and (B) TDBA-β-CD-Pt@Ab2. (C) Illustration
of the Construction of Biosensor for ncovNP Determination.
Experiment Section
Preparation of PDP PNPs
First, tetrahydrofuran (THF)
was applied to dissolve 5.0 mg of PDP and 1.0 mg of PSMA to make their
respective solutions (1.0 mg/mL). Subsequently, the obtained PDP and
PSMA solutions were sufficiently mixed for 2.0 h and further injected
into deionized water (10 mL). Next, the resultant mixed solution was
heated under an air atmosphere at 80 °C until THF was completely
evaporated to obtain a PDP PNP dispersion. Scheme A plots the preparation procedure of PDP
PNPs.
Preparation of the β-CD-Pt Nanocomposite
Briefly,
1.0 mg of β-CD was dissolved in deionized water with vigorous
sonication to form 1.0 mg/mL β-CD solution. Then, 10 μL
of H2PtCl6 (1%) was added to the β-CD
solution and the mixture was intensely stirred overnight. Thereafter,
25 μL of NaBH4 (0.01 M) was slowly added into the
above mixed solution to react for 20 min under stirring. Then, 10
μL of sodium citrate (0.01 M) was added and the mixture was
continuously stirred for 30 min to form the β-CD-Pt nanocomposite,
which was collected by centrifuging at 10 000 rpm and washing
with water three times. Finally, the collected β-CD-Pt was dispersed
in 1.0 mL of water to obtain its dispersion.As a control, the
Pt nanoparticles (Pt NPs) were prepared according to the above reduction
method in the absence of β-CD.
Preparation of the TDBA-β-CD-Pt@Ab2 Composite
The preparation procedure of the secondary
antibody complex (TDBA-β-CD-Pt@Ab2) is depicted in Scheme B. Briefly, 4.0 μL
of TDBA, 400 μL of β-CD-Pt
dispersion, and 40 μL of Ab2 (50 μg/mL) were
mixed and reacted under 4.0 °C for 14 h to form the TDBA-β-CD-Pt@Ab2 nanocomposite. Then, the remaining active sites of TDBA-β-CD-Pt@Ab2 were blocked by incubating BSA (1%, 100 μL) with the
nanocomposite for 40 min. Finally, the resultant TDBA-β-CD-Pt@Ab2 was centrifuged at 8000 rpm and washed three times using
0.10 M PBS (pH 7.4) and further dispersed in 400 μL of 0.10
M PBS (pH 7.4). The obtained product was stored at 4.0 °C for
later use.
Fabrication of the ECL Immunosensor
After being polished
with alumina (0.3 and 0.05 μm) and ultrasonically cleaned alternately
using pure water and ethanol, the GCE (Φ = 4.0 mm) was covered
with the PDP PNP dispersion (10 μL) and naturally dried at room
temperature. Then, the carboxyl groups of PDP PNPs were activated
by incubating the electrode with EDC/NHS (v/v 4:1, 10 μL) for
1.0 h at room temperature. Hereafter, the first antibody (Ab1, 10 μL) was incubated on the modified electrode for 14 h at
4.0 °C. Then, BSA (1%, 10 μL) was further incubated on
a modified electrode for 1.0 h to block remnant binding sites of PDP
PNPs to obtain the ECL immunosensor (Ab1/PDP PNPs/GCE).
PBS (0.10 M, pH 7.4) was used to wash the electrodes in each modification
step. The preparation process is depicted in Scheme C.
ECL Measurement
The immunosensor
(Ab1/PDP
PNPs/GCE) was incubated with different concentrations of ncovNP at
37 °C for 1.0 h, and then the TDBA-β-CD-Pt@Ab2 bioconjugate was captured by incubating it on the electrode surface
at 37 °C for 1.0 h to construct a sandwich structure. The modified
GCE as a working electrode, platinum wire as a counter electrode,
and an Ag/AgCl reference electrode formed a three-electrode system
to record the ECL signals. The ECL detection was performed in 0.10
M of PBS (3.0 mL, pH 7.4). The scanning potential was from 0 V to
+1.5 V and the scanning rate and the photomultiplier tube (PMT) were
set to 300 mV/s and 800 V, respectively.
Results and Discussion
Morphologies
and Element Characterization of Nanomaterials
The scanning
electron microscopy (SEM) and transmission electron
microscopy (TEM) images of the prepared nanomaterials were recorded
to observe their morphologies. Figure A depicts the TEM images of PDP PNPs, which exhibit
a spherical shape with an average diameter of 103 nm. Figure B shows the SEM images of Pt
NPs, which reveal the dissociative Pt NPs with an average size of
about 30 nm. Figure C is the TEM images of the β-CD-Pt nanocomposite and shows
a large number of Pt NPs. The assembly and arrangement of Pt NPs clearly
revealed the cavity structure of the circinate shape of β-CD,
indicating that Pt NPs were grown in situ on the coordination sites
for the metal ions of β-CD. Moreover, the energy-dispersive
scanning (EDS) mapping was employed to ensure the elemental distribution
of β-CD-Pt. Figure D displays the EDS mapping of C, N, O, and Pt elements. It
was demonstrated that Pt NPs were assembled on the β-CD molecules.
Figure 1
(A) TEM
images of PDP PNPs. (B) SEM images of Pt NPs. (C) TEM images
of β-CD-Pt and (D) the corresponding elemental mapping of C,
N, O, and Pt. XPS spectra of (E) PDP PNPs and (F) β-CD-Pt.
(A) TEM
images of PDP PNPs. (B) SEM images of Pt NPs. (C) TEM images
of β-CD-Pt and (D) the corresponding elemental mapping of C,
N, O, and Pt. XPS spectra of (E) PDP PNPs and (F) β-CD-Pt.X-ray photoelectron spectroscopy (XPS) of PDP PNPs
and β-CD-Pt
was explored to further ensure their element distribution. Figure E clearly depicts
the characteristic peaks of C 1s and O 1s from PDP PNPs. The corresponding
XPS spectrum of each element with various bonds is shown in Figure S1A,B, respectively. As seen, the binding
energies of C–C, C–O, and C=O of C 1s are 284.88,
286.29, and 287.6 eV, respectively (Figure S1A), and the binding energies of C–O and C=O in O 1s
are 532.49 and 533.68 eV, respectively (Figure S1B). The existence of the C=O covalent bond indicates
that PDP PNPs were successfully functionalized with carboxyl groups. Figure F depicts the XPS
characteristic peaks of C, O, N, and Pt elements in β-CD-Pt.
The corresponding bonding characteristic peaks of N 1s and Pt 4f are
displayed in Figure S1C,D, respectively.
The binding energies of Pt–N, C–N, and N–H in
N 1s are found to be 398.28, 399.56, and 401.37 eV, respectively (Figure S1C), and the binding energies of Pt–N
4f7/2 and Pt–N 4f5/2 can be observed
to be 72.53 and 76.5 eV, respectively (Figure S1D). The XPS characteristic peaks from β-CD-Pt demonstrate
the successful preparation of β-CD-Pt.In addition, the
preparation of PDP PNPs was further characterized
by Fourier transform-infrared (FT-IR) and ultraviolet–visible
(UV–vis) absorption spectra, and the corresponding results
are shown in Figure S2A,B in the Supporting
Information, respectively. Meanwhile, the fluorescence (FL) excitation
wavelength, the emission wavelength, and the ECL spectrum of PDP PNPs
were explored, and the results are depicted in Figure S2C. Figure S2D displays
the three-dimensional surface image of ECL from PDP PNPs. See the Supporting Information for the detailed discussion
concerning Figure S2A–D. The FT-IR,
UV–vis absorption, and FL spectrum results further demonstrate
the successful preparation of PDP PNPs. The dispersibility in water
and luminescence stability of PDP PNPs were also explored, and Figure S3 depicts the results. The detailed discussion
is presented in the Supporting Information.
ECL Mechanism
The ECL behaviors of different materials
including PDP PNPs, β-CD-Pt, β-CD, and Pt NPs were investigated
using their corresponding modified electrodes in 0.10 M PBS (pH 7.4). Figure A,B depicts the ECL
signals without and with 5.7 mM TDBA in PBS, respectively. As seen,
whether or not co-reactant TDBA was present, almost no ECL signals
were detected at β-CD-Pt/GCE (curve b), β-CD/GCE (curve
c), and Pt NPs/GCE (curve d). However, the PDP PNPs/GCE exhibited
a weak ECL signal (Figure A, curve a) in the absence of TDBA and a strong ECL response
at +1.5 V in the presence of TDBA (Figure B, curve a), indicating that the detected
ECL emission originated from PDP PNPs, not β-CD or Pt NPs. Moreover,
it was also revealed that TDBA can act as a co-reactant to enhance
the ECL signal of PDP PNPs. Meanwhile, the effect of PSMA on the ECL
signal of the prepared PDP PNPs was confirmed by comparing the ECL
responses of PDP nanoparticles with and without PSMA, and the corresponding
descriptions are presented in the Supporting Information and the results
are given in Figure S4.
Figure 2
(A) ECL responses of
differently modified electrodes (A) without
and (B) with 5.7 mM TDBA: (a) PDP PNPs/GCE, (b) β-CD-Pt/GCE,
(c) β-CD/GCE, and (d) Pt NPs/GCE. (C) ECL stability of (a) PDP
PNPs/GCE with 5.7 mM TDBA and (b) TDBA-Pt@Ab2/ncovNP/Ab1/PDP PNPs/GCE. (D) ECL signals of (a) TDBA-β-CD-Pt@Ab2/ncovNP/Ab1/PDP PNPs/GCE and (b) TDBA-Pt@Ab2/ncovNP/Ab1/PDP PNPs/GCE. (E) Anodic DPV profiles
of (a) bare GCE with 5.7 mM TDBA, (b) TDBA-β-CD-Pt@Ab2/ncovNP/Ab1/PDP PNPs/GCE, and (c) TDBA-Pt@Ab2/ncovNP/Ab1/PDP PNPs/GCE. (F) EPR spectra of (a) TDBA-β-CD-Pt
and (b) TDBA-Pt under light irradiation. Detection solution of PBS
(3.0 mL, 0.10 M, pH 7.4) and the scanning rate of 300 mV/s for ECL
and 100 mV/s for DPV.
(A) ECL responses of
differently modified electrodes (A) without
and (B) with 5.7 mM TDBA: (a) PDP PNPs/GCE, (b) β-CD-Pt/GCE,
(c) β-CD/GCE, and (d) Pt NPs/GCE. (C) ECL stability of (a) PDP
PNPs/GCE with 5.7 mM TDBA and (b) TDBA-Pt@Ab2/ncovNP/Ab1/PDP PNPs/GCE. (D) ECL signals of (a) TDBA-β-CD-Pt@Ab2/ncovNP/Ab1/PDP PNPs/GCE and (b) TDBA-Pt@Ab2/ncovNP/Ab1/PDP PNPs/GCE. (E) Anodic DPV profiles
of (a) bare GCE with 5.7 mM TDBA, (b) TDBA-β-CD-Pt@Ab2/ncovNP/Ab1/PDP PNPs/GCE, and (c) TDBA-Pt@Ab2/ncovNP/Ab1/PDP PNPs/GCE. (F) EPR spectra of (a) TDBA-β-CD-Pt
and (b) TDBA-Pt under light irradiation. Detection solution of PBS
(3.0 mL, 0.10 M, pH 7.4) and the scanning rate of 300 mV/s for ECL
and 100 mV/s for DPV.We compared the stability
of ECL signals with the co-reactant TDBA
added to the detection solution and immobilized onto the electrode
surface. Figure C
depicts the corresponding results. For TDBA (5.7 mM) in PBS, the ECL
signals under successive potential scanning for 10 cycles were recorded
at PDP PNPs/GCE, and the results are plotted in Figure C (curve a). When TDBA was immobilized on
the GCE, the ECL signal was detected at the biosensor TDBA-β-CD-Pt@Ab2/ncovNP/Ab1/PDP PNPs/GCE. The results are presented in Figure C (curve b). As observed, curve
a shows decreasing ECL signals as the number of cyclic scans increases
and the relative standard deviation (RSD) is 12.9%. However, curve
b shows a stable ECL emission under the same number of cyclic scans,
and the corresponding RSD was 4.06%, which revealed the superiority
of immobilizing TDBA onto the electrode by the β-CD-Pt nanocomposite.The amplification effect of β-CD on the ECL emission of PDP
PNPs was further explored. As a comparison, TDBA-Pt@Ab2/ncovNP/Ab1/PDP PNPs/GCE without β-CD was also constructed
using the same assembly method as the biosensor (TDBA-β-CD-Pt@Ab2/ncovNP/Ab1/PDP PNPs/GCE) by substituting TDBA-Pt
for TDBA-β-CD-Pt. As seen from Figure D, the ECL signal strength without β-CD
was about 1978 a.u. (curve b). Nevertheless, the ECL signal strength
of the biosensor with β-CD was about 9760 a.u., showing nearly
fivefold enhancement than that without β-CD. It was demonstrated
that our developed hydrophobic localized enrichment strategy of the
co-reactant TDBA utilizing the hydrophobic cavity of β-CD could
significantly enhance ECL emission and improve the detection sensitivity.The electrochemical oxidation of co-reactant TDBA on different
modified electrodes was explored using differential pulse voltammetry
(DPV). First, the DPV profile in the case of TDBA being added to PBS
was explored using the bare GCE, and the result is plotted in Figure E (curve a). A strong
oxidation peak of TDBA was detected at +0.90 V, which was assigned
to the production of TDBA• during
the positive potential scanning. Subsequently, the DPV profile in
the case of TDBA being immobilized by hydrophobic localized enrichment
and covalent bonding was explored using TDBA-β-CD-Pt@Ab2/ncovNP/Ab1/PDP PNPs/GCE, and the result is plotted
in Figure E (curve
b), which shows a relatively strong oxidation peak at +0.90 V. Finally,
the DPV profile with TDBA being immobilized only by covalent bonding
(Pt–N bond) was also explored using TDBA-Pt@Ab2/ncovNP/Ab1/PDP PNPs/GCE, and the result is plotted in Figure E (curve c), which shows a
dramatically decreased oxidation peak in the absence of β-CD.
The above experiments confirmed that the hydrophobic cavity of β-CD
could effectively enrich TDBA to produce more TDBA•, thus improving ECL emission from PDP PNPs.In addition, the electron paramagnetic resonance (EPR) was performed
using 5,5-dimethyl-1-pyrroline N-oxide (DMPO) as TDBA radical scavenger
to further confirm the hydrophobic localized enrichment of TDBA by
β-CD. As seen from Figure F, under light irradiation, the EPR signal from the
DMPO–TDBA adduct in the presence of β-CD is stronger
than that without β-CD, indicating that β-CD with an inner
hydrophobic cavity could effectively enrich TDBA.The possible
ECL mechanism of the biosensor may be supposed as
follows. First, the PDP PNPs and co-reactant TDBA were electro-oxidized
to generate PDP PNPs•+ and TDBA•, respectively. In the absence of β-CD (Scheme , without β-CD),
less TDBA would be produced when TDBA• was immobilized only by covalent bonding (Pt–N
bond), and then less TDBA would be produced
through loss proton (H+), thereby producing less excited
species PDP PNPs*. Remarkably, in the presence of β-CD
(Scheme , with β-CD),
more TDBA• would be generated due
to the hydrophobic interaction between TDBA and β-CD, and then
TDBA• would lose H+ to
produce more TDBA, which further crashed
with PDP PNPs to form abundant PDP
PNPs*, thus significantly promoting the ECL emission of the PDP PNPs/TDBA
system.
Scheme 2
ECL Mechanisms of PDP PNPs/TDBA System without and with β-CD
Optimization of Experimental Conditions
Both cyclic
voltammetry (CV) and electrochemical impedance spectroscopy (EIS)
were applied to confirm the successful assembly of the biosensor (TDBA-β-CD-Pt@Ab2/ncovNP/Ab1/PDP PNPs/GCE), and Figure S5A,B plots the corresponding results, respectively.
The corresponding discussions were described in the Supporting Information.The optimization of experimental
conditions is necessary for the analysis and application of the biosensor.
In this work, the pH of PBS, the concentration of Ab2,
and the incubation time for ncovNP and Ab2 were optimized
using the biosensor TDBA-β-CD-Pt@Ab2/ncovNP/Ab1/PDP PNPs/GCE with 1.0 ng/mL ncovNP. Figure A plots the change of response signal with
pH. It was observed that the ECL signal went up with increasing pH
from 4.0 to 7.4, reaching its maximum at pH 7.4. The ECL intensity
decreased gradually as pH exceeded 7.4. This phenomenon may be explained
as the physiological pH is beneficial to the maintenance of bioactivity
of the antibody and the antigen.
Figure 3
Effect of (A) pH of PBS, incubation time
for (B) ncovNP and (C)
Ab2, and (D) concentration of Ab2 on the ECL
response at the biosensor incubated with 1.0 ng/mL ncovNP in PBS (3.0
mL, 0.10 M, pH 7.4). Scanning rate: 300 mV/s.
Effect of (A) pH of PBS, incubation time
for (B) ncovNP and (C)
Ab2, and (D) concentration of Ab2 on the ECL
response at the biosensor incubated with 1.0 ng/mL ncovNP in PBS (3.0
mL, 0.10 M, pH 7.4). Scanning rate: 300 mV/s.Figure B,C plots
changes in response signal with the incubation time of ncovNP and
Ab2, respectively. As seen, the response signal gradually
increased with the increasing incubation time and reached the maximum
at 60 min. When the incubation time exceeded 60 min, the ECL intensity
dropped slightly and gradually stabilized. Thus, the incubation time
of 60 min was considered as the optimal incubation time for ncovNP
and Ab2 in this work.Figure D plots
the change in the response signal with the concentration of Ab2. As seen, the ECL intensity increased as the concentration
of Ab2 ranged from 1.0 to 50 μg/mL. When the concentration
exceeded 50 μg/mL, the ECL intensity decreased slightly and
gradually stabilized. Thus, the concentration of 50 μg/mL was
viewed as the optimizing concentration of Ab2 in this work.Furthermore, the amplification effects of different amines on the
ECL emission of luminophore PDP PNPs were explored. The results are
depicted in Figure S6 and the detailed
discussions are presented in the Supporting Information. The results indicated that TDBA was an optimal co-reactant for
PDP PNPs.
Analytical Performance of the Immunosensor
The application
of ECL biosensor was first explored by quantitative bioassay of target
ncovNP, and the results are plotted in Figure A,B. The ECL response in 3.0 mL of PBS (0.10
M, pH 7.4) gradually enlarged as the concentrations of ncovNP ranged
from 50 fg/mL to 1.0 ng/mL. Over this concentration range, the ECL
intensity showed a good linear relationship with the logarithm of
the concentration, and the detection limit as low as 22 fg/mL was
obtained at the biosensor with a signal-to-noise ratio (S/N) of 3.
The detailed calculation is presented in the Supporting Information. Compared to other works for ncovNP detection,
the proposed ECL biosensor had a wider linear range and a lower detection
limit. The comparison is depicted in Table .
Figure 4
(A) ECL response of the biosensor TDBA-β-CD-Pt@Ab2/ncovNP/Ab1/PDP PNPs/GCE toward ncovNP (a) to (g):
50,
100 fg/mL, 1.0, 10, 100 pg/mL, 500 pg/mL, and 1.0 ng/mL. (B) Calibration
curve for ncovNP detection. (C) ECL response to ncovNP (1 ng/mL) alone,
blank sample, 100 ng/mL of interfering substance (BSA, CEA, and AFP)
alone, and their mixtures in 3.0 mL of PBS (0.10 M, pH 7.4). (D) Stability
of the biosensor with ncovNP (100 pg/mL). Scanning rate: 300 mV/s.
Table 1
Comparison of the Analytical Performance
of Different ncovNP Detection Strategies
detection
method
linear range
LOD
refs
immunochromatographic sensor
0.05–1.6 ng/mL
0.026 ng/mL
(27)
fluorescent
immunoassay
0–120 ng/mL
0.33 ng/mL
(28)
voltammetric-based
Immunosensor
100 ng/mL–1.0 pg/mL
0.4 pg/mL
(29)
half-strip
lateral flow
assay
0.53–0.77 ng/mL
0.65 ng/mL
(30)
electrochemical
immunosensor
0.1 pg/mL–1 μg/mL
0.8 pg/mL
(1)
ECL immunosensor
50 fg/mL–1.0 ng/mL
22 fg/mL
this work
(A) ECL response of the biosensor TDBA-β-CD-Pt@Ab2/ncovNP/Ab1/PDP PNPs/GCE toward ncovNP (a) to (g):
50,
100 fg/mL, 1.0, 10, 100 pg/mL, 500 pg/mL, and 1.0 ng/mL. (B) Calibration
curve for ncovNP detection. (C) ECL response to ncovNP (1 ng/mL) alone,
blank sample, 100 ng/mL of interfering substance (BSA, CEA, and AFP)
alone, and their mixtures in 3.0 mL of PBS (0.10 M, pH 7.4). (D) Stability
of the biosensor with ncovNP (100 pg/mL). Scanning rate: 300 mV/s.The selectivity of the biosensor was further investigated
in the
case of BSA, carcinoembryonic antigen (CEA), and α-fetoprotein
(AFP) as possible interfering substances. The ECL responses of the
modified electrode toward target ncovNP (1.0 ng/mL), blank sample,
selected interfering substance with a concentration of 100-fold ncovNP,
and their mixtures were measured in 3.0 mL of PBS (0.10 M, pH 7.4).
The results are shown in Figure C. As plotted, a strong ECL signal was observed in
the case of ncovNP (1.0 ng/mL) alone and the mixtures containing ncovNP
(1.0 ng/mL) and interfering substances. Moreover, the response was
almost identical in both cases. Compared with the response toward
ncovNP (1.0 ng/mL), the response to the interfering substances can
be ignored, demonstrating good selectivity of the biosensor for ncovNP.Stability is very important for the biosensor. The ECL signals
at the biosensor incubated with 100 pg/mL ncovNP were recorded during
10 cycles of continuous potential scanning, and Figure D plots the results. As seen, the ECL response
showed no significant change, and the relative standard deviation
(RSD) of 2.95% was obtained, showing acceptable stability of the proposed
ECL biosensor.The reproducibility was also explored. The four
biosensors constructed
in the same batch and in different batches were used to perform the
intra-assays and interassays in 3.0 mL of PBS (0.10 M, pH 7.4), respectively,
and the results are shown in Figure S7.
The RSDs in the intra-assays and interassays were 3.79 and 3.32%,
respectively, demonstrating a favorable reproducibility of the proposed
ECL biosensor.
Analysis of Real Serum Samples
To
test the practicality
of our constructed biosensors, recovery experiments were performed
in serum using a standard addition method. The concentration of ncovNP
in diluted serum with 50 fold was evaluated. Subsequently, ncovNP
was added in three different concentrations in diluted serum to detect
the recovery rates. As presented in Table S1, the recovery rates were in the range of 98.0–99.2%, indicating
that the ECL platform was feasible for detecting ncovNP in real serum
samples.
Conclusions
In this work, β-cyclodextrin
(β-CD) with an inner hydrophobic
cavity was innovatively developed to achieve a hydrophobic localized
enrichment of co-reactant TDBA. Meanwhile, the coordination sites
for metal ions of β-CD make it easy for Pt NPs to grow in situ
on β-CD, which also could achieve the immobilization of TDBA
via the Pt–N bond. The synergy of two forces, namely, hydrophobic
localized enrichment and covalent bonding, resulted in a high loading
of TDBA on the electrode surface. Meanwhile, the novel PDP PNPs with
excellent ECL performance opened up a promising ECL polymer luminophore.
The integration of the TDBA-β-CD-Pt nanocomposite and PDP PNPs
achieved a sensitive detection of ncovNP, providing a new method for
ncovNP. More importantly, β-CD shared with an inspiration in
hydrophobic localized enrichment of co-reactants for improving the
sensitivity of ECL detection.
Authors: Fatima Amanat; Daniel Stadlbauer; Shirin Strohmeier; Thi H O Nguyen; Veronika Chromikova; Meagan McMahon; Kaijun Jiang; Guha Asthagiri Arunkumar; Denise Jurczyszak; Jose Polanco; Maria Bermudez-Gonzalez; Giulio Kleiner; Teresa Aydillo; Lisa Miorin; Daniel S Fierer; Luz Amarilis Lugo; Erna Milunka Kojic; Jonathan Stoever; Sean T H Liu; Charlotte Cunningham-Rundles; Philip L Felgner; Thomas Moran; Adolfo García-Sastre; Daniel Caplivski; Allen C Cheng; Katherine Kedzierska; Olli Vapalahti; Jussi M Hepojoki; Viviana Simon; Florian Krammer Journal: Nat Med Date: 2020-05-12 Impact factor: 53.440
Authors: Benjamin D Grant; Caitlin E Anderson; John R Williford; Luis F Alonzo; Veronika A Glukhova; David S Boyle; Bernhard H Weigl; Kevin P Nichols Journal: Anal Chem Date: 2020-08-05 Impact factor: 6.986